2011
DOI: 10.1258/phleb.2010.010052
|View full text |Cite
|
Sign up to set email alerts
|

In vitro effect of calcium dobesilate on oxidative/inflammatory stress in human varicose veins

Abstract: Calcium dobesilate protected human varicose veins against oxidative stress in vitro at levels that correspond to therapeutic concentrations. Further studies are required to investigate whether a similar action is found in varicose veins from patients orally treated with calcium dobesilate.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
10
0
1

Year Published

2014
2014
2021
2021

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 21 publications
(11 citation statements)
references
References 21 publications
(33 reference statements)
0
10
0
1
Order By: Relevance
“…The obtained results showed that the drug significantly improved antioxidant defense. 29 Calcium dobesilate is a drug strengthening blood vessels, commonly used in patients with CVI and thrombotic disease of the lower limbs. 30 The surgery technique used in the stripping of the GSV differs from the harvesting of the GSV used in the CABG surgery.…”
Section: Discussionmentioning
confidence: 99%
“…The obtained results showed that the drug significantly improved antioxidant defense. 29 Calcium dobesilate is a drug strengthening blood vessels, commonly used in patients with CVI and thrombotic disease of the lower limbs. 30 The surgery technique used in the stripping of the GSV differs from the harvesting of the GSV used in the CABG surgery.…”
Section: Discussionmentioning
confidence: 99%
“…In this sense, the fish oil emulsion, rich in Ω-3 polyunsaturated fatty acids, has anti-inflammatory and antioxidant in vitro properties, with the capability to inhibit the production of pro-inflammatory growth factors and cytokines [ 22 ]. Table 1 summarizes the main in vitro studies on antioxidants and their results as possible therapeutic agents for DR treatment [ 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 ].…”
Section: In Vitro Experimentsmentioning
confidence: 99%
“…30 In our study, patients in the calcium dobesilate group also showed a statistically significant improvement in the CIVIQ sub score “pain or discomfort in ankles or legs during the past four weeks” at the end of treatment, suggesting that the benefits of calcium dobesilate treatment were becoming apparent at the end of the treatment period. These findings suggest the possibility of a sustained and progressive therapeutic effect of calcium dobesilate in CVI, possibly due to its anti-inflammatory actions, 31,32 which would presumably result in a sustained effect over the long term even after drug intake has been stopped. It may also be hypothesized that pain or discomfort improved because of the primary effects of calcium dobesilate on the venous system, and that these effects did not immediately translate into a lower level of edema.…”
Section: Discussionmentioning
confidence: 93%